AMDI Unveils Autolab™ HBH System, Transforming Diagnostics

Author: Dylan Bailey Updated: 04-14-2025 02:09 AM

AMDI Unveils Autolab™ HBH System at ESCMID 2025

Autonomous Medical Devices Incorporated (AMDI) has launched its groundbreaking Autolab™ HBH system, showcasing the future of sample preparation technology at the ESCMID Global Congress 2025. This innovative system is poised to revolutionize molecular workflows, making significant strides in both research and diagnostic applications.

Revolutionizing Sample Preparation

The Autolab™ HBH system employs AMDI's innovative Hyperbaric Heating (HBH) technology to dramatically enhance the efficiency of sample preparation. Unlike traditional methods, which can take upwards of 20 to 45 minutes, the Autolab HBH completes the entire process in under two minutes. This swift turnaround not only optimizes laboratory operations but also significantly reduces the use of costly extraction kits that often involve intricate manual steps.

Efficiency at the Forefront

During its launch, David Okrongly, CEO of AMDI, emphasized the importance of this technology in addressing the longstanding hurdles in sample preparation, which have traditionally revolved around complexity, cost, and time. "Our mission is to equip laboratories with advanced tools that enhance both access to and the quality of molecular testing, from PCR to sequencing," he stated.

Diverse Applications for Autolab™ HBH

One of the standout features of the Autolab™ HBH is its versatility in handling various sample matrices. This characteristic allows it to serve a wide range of fields including clinical research, environmental monitoring, and public health. Currently positioned for research use only (RUO), this product demonstrates AMDI's commitment to supporting diverse laboratory needs.

Live Demonstrations at ESCMID

Attendees of the ESCMID 2025 conference can experience live demonstrations of the Autolab™ HBH at Booth #D760. This hands-on opportunity provides an insight into how the Autolab™ HBH can streamline processes and improve outcomes in real-world settings.

About Autonomous Medical Devices Incorporated

AMDI is a California-based diagnostic technology pioneer dedicated to crafting next-generation solutions aimed at improving speed, access, and accuracy in molecular testing. All products are meticulously developed and manufactured in an ISO 13485-certified facility located in Santa Ana, CA.

Contact Information

For media inquiries, please reach out to Brian Miller.

Frequently Asked Questions

What is Autolab™ HBH?

The Autolab™ HBH is a sample preparation system designed to improve efficiency in molecular diagnostics by using Hyperbaric Heating technology.

How does the Autolab™ HBH improve sample preparation?

It reduces processing time to under two minutes, streamlining workflows and minimizing the reliance on traditional extraction kits.

Is the Autolab™ HBH available for commercial use?

Currently, the Autolab™ HBH is only available for research use as indicated by the RUO (Research Use Only) status.

In what fields can the Autolab™ HBH be utilized?

The system is adaptable for clinical research, public health, environmental monitoring, and various other applications.

Where can I see the Autolab™ HBH in action?

Live demonstrations of the system are taking place at the ESCMID 2025 conference at Booth #D760.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.